Share chart Kiniksa Pharmaceuticals, Ltd.
Extended chart
Simple chart
About
Kiniksa Pharmaceuticals, Ltd., биофармацевтическая компания на клинической стадии, специализируется на обнаружении, приобретении, разработке и коммерциализации терапевтических лекарств для пациентов, страдающих тяжелыми заболеваниями, со значительными неудовлетворенными медицинскими потребностями во всем мире. more details| IPO date | 2018-05-24 |
|---|---|
| ISIN | BMG5269C1010 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.kiniksa.com |
| Цена ао | 19.25 |
| Change price per day: | -3.41% (19.93) |
|---|---|
| Change price per week: | -3.85% (20.02) |
| Change price per month: | -4.42% (20.14) |
| Change price per 3 month: | -27.71% (26.63) |
| Change price per half year: | -10.09% (21.41) |
| Change price per year: | +2.01% (18.87) |
| Change price per 3 year: | +73.74% (11.08) |
| Change price per 5 year: | +64.53% (11.7) |
| Change price per 10 year: | 0% (19.25) |
| Change price per year to date: | -4.94% (20.25) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Blackrock Inc. | 3180588 | 7.96 |
| Vanguard Group Inc | 2965299 | 7.42 |
| Rubric Capital Management LP | 2907501 | 7.27 |
| Fairmount Funds Management LLC | 2883221 | 7.21 |
| Baker Brothers Advisors, LLC | 2809577 | 7.03 |
| Morgan Stanley | 1595479 | 3.99 |
| Pictet Asset Management Holding SA | 1570816 | 3.93 |
| State Street Corporation | 1546096 | 3.87 |
| Goldman Sachs Group Inc | 909212 | 2.27 |
| Granahan Investment Management LLC | 722388 | 1.81 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.24336 | 13.79 | 1.54048 |
| iShares MSCI USA Small-Cap Min Vol Factor ETF | 0.20453 | 16.5 | 1.66828 |
| Future Tech ETF | 0.10086 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.10086 | 618.5 | 0.8416 |
iShares Russell 2000 Growth ETF
|
0.07074 | 38.04 | 0.6026 |
| iShares Morningstar Small-Cap Growth ETF | 0.01991 | 33.63 | 0.72598 |
| iShares Morningstar Small-Cap Growth ETF | 0.01991 | 590.83 | 0.72598 |
| iShares Morningstar Small-Cap ETF | 0.01797 | 30.1 | 1.60498 |
| iShares Morningstar Small-Cap ETF | 0.01797 | 391.25 | 1.60498 |
| iShares Morningstar Small Cap Value ETF | 0.01723 | 26.7 | 2.50476 |
| iShares Morningstar Small-Cap Value ETF | 0.01723 | 199.14 | 2.50476 |
| iShares Russell 3000 ETF | 0.002 | 23.61 | 1.43482 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Sanj K. Patel | CEO & Chairman of the Board | 1.44M | 1969 (56 years) |
| Mr. Mark Ragosa C.F.A. | Senior VP & CFO | N/A | 1974 (51 year) |
| Mr. Chad Morin | Senior VP & Chief Compliance Officer | N/A | |
| Mr. Eben Tessari | Senior VP & COO | 643.75k | 1982 (43 years) |
| Mr. Michael R. Megna CPA | Chief Accounting Officer & Group VP of Finance | N/A | 1971 (54 years) |
| Ms. Mei Jang | Senior Vice President of Technical Operations | N/A | |
| Ms. Madelyn Demsky Zeylikman | SVP, General Counsel & Secretary | N/A | 1974 (51 year) |
| Dr. John F. Paolini FACC, M.D., Ph.D. | Senior VP & Chief Medical Officer | 1965 (60 years) | |
| Mr. Carsten Boess | Executive Vice President of Corporate Affairs | 1966 (59 years) | |
| Ms. Martina Struck Ph.D. | Senior Vice President of Regulatory Affairs |
Address: Bermuda, Hamilton HM , Clarendon House - open in Google maps, open in Yandex maps
Website: http://www.kiniksa.com
Website: http://www.kiniksa.com
